Outcome Idiopathic Intracranial Hypertension in Terms of Papilledema Improvement Following Lumboperitoneal Shunt: Experience at Khyber Teaching Hospital
DOI:
https://doi.org/10.36283/ziun-pjmd14-4/049Keywords:
Idiopathic intracranial hypertension, Papilledema, LP Shunt, Statistical analysisAbstract
Background: Background: Idiopathic intracranial hypertension or pseudotumor cerebri is a clinical entity characterized by symptoms and signs of elevated intracranial pressure, cerebrospinal fluid opening pressure >25 cm H₂O, normal cerebrospinal fluid composition, and absence of radiological evidence of causative lesions on magnetic resonance imaging or computed tomography. Treatment options vary from conservative to surgical. The use of Lumboperitoneal Shunt has been well documented as treatment modality for patient with idiopathic intracranial hypertension.
Objective: To evaluate the outcome of idiopathic intracranial hypertension in terms of improvement in papilledema following lumboperitoneal shunt placement and to analyze predictive factors for treatment success.
Methodology: This cross-sectional descriptive study was conducted at Khyber Teaching hospital Peshawar from June 2023 to June 2025 among 32 patients. Study design was non-probability purposive. Informed consent was obtained from all patients. Female patients with age range from 18 to 45 years with diagnosed cases of IIH were included. Statistical analysis included chi-square tests, paired t-tests, Fisher's exact test, and correlation analysis using SPSS version 28.
Results: Among 32 female participants (mean age: 32.8±2.1 years), pre-surgical fundoscopic examination revealed grade 1 papilledema in 18 cases (56.2%) and grade 2 in 14 cases (43.8%). Mean cerebrospinal fluid opening pressure measured 38.2±4.5 cm H₂O (range: 28-48). Following lumboperitoneal shunt insertion, optic disc swelling resolved in 29 patients (90.6%), while cephalgia subsided in 26 cases (81.3%). Surgical intervention within six months of symptom onset demonstrated superior therapeutic efficacy compared to delayed procedures (100% vs 76.9% papilledema resolution; OR=4.44,95% CI [1.12-17.62], p=0.032). Post-surgical CSF pressure reduction proved statistically robust (mean decrease: 20.7±5.4 cm H₂O; t=21.760, p<0.001).
Conclusion: Lumboperitoneal shunt demonstrates excellent efficacy for papilledema improvement in IIH with 90.6% success rate. Early intervention before advanced papilledema develops is crucial for optimal outcomes. The procedure has acceptable complication rates and should be considered in medically refractory cases.
References
1. Toshniwal SS, Kinkar J, Chadha Y, et al. Navigating the Enigma: A Comprehensive Review of Idiopathic Intracranial Hypertension. Cureus. 2024;16(3):e56256. Published 2024 Mar 16. doi:10.7759/cureus.56256
2. Zhou C, Zhou Y, Liu L, et al. Progress and recognition of idiopathic intracranial hypertension: A narrative review. CNS Neurosci Ther. 2024;30(8):e14895. doi:10.1111/cns.14895
3. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59(10):1492-1495. doi:10.1212/01.wnl.0000029570.69134.1b
4. Korsbæk JJ, Jensen RH, Høgedal L, Molander LD, Hagen SM, Beier D. Diagnosis of idiopathic intracranial hypertension: A proposal for evidence-based diagnostic criteria. Cephalalgia. 2023;43(3):3331024231152795. doi:10.1177/03331024231152795
5. Frisén L. Swelling of the optic nerve head: a staging scheme. J Neurol Neurosurg Psychiatry. 1982;45(1):13-18. doi:10.1136/jnnp.45.1.13
6. Salih M, Enriquez-Marulanda A, Khorasanizadeh M, Moore J, Prabhu VC, Ogilvy CS. Cerebrospinal Fluid Shunting for Idiopathic Intracranial Hypertension: A Systematic Review, Meta-Analysis, and Implications for a Modern Management Protocol [published correction appears in Neurosurgery. 2023 Feb 01;92(2):e45. doi: 10.1227/neu.0000000000002282.]. Neurosurgery. 2022;91(4):529-540. doi:10.1227/neu.0000000000002086
7. Adham RA, Hany M, Yasser AA. The Incidence Rate of Complications among Patients of Benign Intracranial Hypertension after Lumbo-Peritoneal Shunt Procedure Operation. Open Journal of Modern Neurosurgery. 2024 ;15(1):7-22.
8. Yang TH, Chang CS, Sung WW, Liu JT. Lumboperitoneal Shunt: A New Modified Surgical Technique and a Comparison of the Complications with Ventriculoperitoneal Shunt in a Single Center. Medicina (Kaunas). 2019;55(10):643. Published 2019 Sep 26. doi:10.3390/medicina55100643
9. Mollan SP, Davies B, Silver NC, et al. Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry. 2018;89(10):1088-1100. doi:10.1136/jnnp-2017-317440
10. Hamedani AG, Thibault DP, Revere KE, et al. Trends in the Surgical Treatment of Pseudotumor Cerebri Syndrome in the United States. JAMA Netw Open. 2020;3(12):e2029669. Published 2020 Dec 1. doi:10.1001/jamanetworkopen.2020.29669
11. Kalyvas AV, Hughes M, Koutsarnakis C, et al. Efficacy, complications and cost of surgical interventions for idiopathic intracranial hypertension: a systematic review of the literature. Acta Neurochir (Wien). 2017;159(1):33-49. doi:10.1007/s00701-016-3010-2
12. Mollan SP, Aguiar M, Evison F, Frew E, Sinclair AJ. The expanding burden of idiopathic intracranial hypertension. Eye (Lond). 2019;33(3):478-485. doi:10.1038/s41433-018-0238-5
13. Ulivieri S, Oliveri G, Georgantzinou M, et al. Long-term effectiveness of lumboperitoneal flow-regulated shunt system for idiopathic intracranial hypertension. J Neurosurg Sci. 2009;53(3):107-111.
14. Sunderland GJ, Jenkinson MD, Conroy EJ, Gamble C, Mallucci CL. Neurosurgical CSF Diversion in Idiopathic Intracranial Hypertension: A Narrative Review. Life (Basel). 2021;11(5):393. Published 2021 Apr 26. doi:10.3390/life11050393
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Medicine and Dentistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/
Metrics
How to Cite
